Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer.
about
Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesisThe role of vascular endothelial growth factor a polymorphisms in breast cancerMesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-βA systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport.A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trapThe prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative OncoOpposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes.Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia.A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1.Increased plasma levels of soluble vascular endothelial growth factor receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese women.Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer.Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cellsThe association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health StudyHigh levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancerPrognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages.Vascular endothelial growth factor receptor-1 expression in breast cancer and its correlation to vascular endothelial growth factor aSplice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.Effects of diabetes on myocardial capillary density and serum angiogenesis biomarkers in male ratsDiabetic retinopathy and vascular endothelial growth factor.Expression and clinical significance of vascular endothelial growth factor and fms-related tyrosine kinase 1 in colorectal cancerRole of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction.The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma.Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab
P2860
Q21245720-7F91857D-8555-427A-B598-9C3A47D810D3Q26851522-4F63465C-7597-4673-AD96-D9BE978949D0Q27305351-B5E58354-EA37-4A30-9865-28BB27D79A7DQ30433214-EFE20430-2F7B-4F9B-8AF7-CECA035AED03Q30436024-B885CE77-DA9D-4EE6-A299-DA2D83A12CEBQ30439884-E0E7C982-B47E-47F4-ACFD-86728B571D56Q33739381-90823117-8ECE-4C0A-A024-1BB564E39AD8Q34568910-FC8EFC7D-8E91-462F-ACFE-756155916F15Q34731047-845DDAAD-5CEB-4AF0-836F-FA06D6249818Q35856748-E19A7802-096D-4715-9848-2ACAFBC9BA50Q36253217-69FE594C-67FD-411E-B81C-7D8769F5A224Q36611325-3A50EA0D-DD05-4B3B-8415-0B176FC7DAAFQ36615554-7A702107-895F-4B39-99A5-022D3BA5FD4DQ36807110-7509EF21-D1E6-4D9F-9DFA-89642692C125Q37077487-E861CDA4-2407-4EFB-B09E-4FD3C098796DQ37083038-91D775E3-1834-4AD9-BBC2-FA721AF94661Q37187766-F8E63409-08C1-44F8-AFCC-5180F0BE12FEQ37293838-69793015-C8E2-4602-BB89-D7296598C21EQ37422370-FCC0CC2D-5647-4F9B-9484-6B6BE3D49927Q37690917-F5147D44-C842-4C26-BFE5-A65C6498F4C7Q38258872-4896BF02-3A39-424D-B09E-7F6543F93D7AQ41836659-5DF86C19-0DAD-42E0-BDB1-0612E8BEE9C4Q42433614-905547C0-EEB9-4F02-86FF-51E7168DA5CAQ47192395-C7C59E77-7F8C-4B3B-9645-078A8332A7A7Q54978333-E4E70D72-01BA-4BFB-BB1A-82BACF3FB786Q58130125-16D5521D-EA21-4773-9E72-B764B659B534
P2860
Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Association between intratumor ...... nd prognosis in breast cancer.
@ast
Association between intratumor ...... nd prognosis in breast cancer.
@en
type
label
Association between intratumor ...... nd prognosis in breast cancer.
@ast
Association between intratumor ...... nd prognosis in breast cancer.
@en
prefLabel
Association between intratumor ...... nd prognosis in breast cancer.
@ast
Association between intratumor ...... nd prognosis in breast cancer.
@en
P2093
P2860
P356
P1476
Association between intratumor ...... nd prognosis in breast cancer.
@en
P2093
M Brokelmann
S Horiguchi
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602374
P407
P577
2005-02-01T00:00:00Z
P5875
P6179
1053702710